Transformation-Specific Transcription Differentiation by the Related E 26 Regulation of Follicular B Cell and

[1]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.

[2]  E. Clark,et al.  Absence of Mature Peripheral B Cell Populations in Mice with Concomitant Defects in B Cell Receptor and BAFF-R Signaling1 , 2009, The Journal of Immunology.

[3]  B. Blom,et al.  New insights into the regulation of human B-cell differentiation. , 2009, Trends in immunology.

[4]  J. Weill,et al.  Human marginal zone B cells. , 2009, Annual review of immunology.

[5]  F. Camargo,et al.  Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c , 2009, Nature Immunology.

[6]  K. Murphy,et al.  Critical role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis , 2008, Nature.

[7]  R. DeKoter,et al.  Transgenic expression of Spi‐C impairs B‐cell development and function by affecting genes associated with BCR signaling , 2008, European journal of immunology.

[8]  G. Gilkeson,et al.  The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice1 , 2008, The Journal of Immunology.

[9]  Michelle M. Sandau,et al.  Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation , 2008, Nature Immunology.

[10]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[11]  S. Pillai,et al.  Peripheral B cell subsets. , 2008, Current opinion in immunology.

[12]  Z. Weng,et al.  Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies , 2008, Nature Methods.

[13]  C. Boboila,et al.  The Recirculating B Cell Pool Contains Two Functionally Distinct, Long-Lived, Posttransitional, Follicular B Cell Populations1 , 2007, The Journal of Immunology.

[14]  R. DeKoter,et al.  Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. , 2007, Experimental Hematology.

[15]  L. Wysocki,et al.  Identification of anergic B cells within a wild-type repertoire. , 2006, Immunity.

[16]  T. Malek,et al.  Redundant and unique regulation of activated mouse B lymphocytes by IL‐4 and IL‐21 , 2006, Journal of leukocyte biology.

[17]  A. Emelyanov,et al.  Spi-C Has Opposing Effects to PU.1 on Gene Expression in Progenitor B Cells1 , 2006, The Journal of Immunology.

[18]  P. Matthias,et al.  The Ets factor Spi-B is a direct critical target of the coactivator OBF-1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  David Allman,et al.  Regulation of peripheral B cell maturation. , 2006, Cellular immunology.

[20]  Li Wu,et al.  The development of functional B lymphocytes in conditional PU.1 knock-out mice. , 2005, Blood.

[21]  K. Akashi,et al.  Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. , 2005, Blood.

[22]  L. Garrett-Sinha,et al.  Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. , 2005, International immunology.

[23]  L. Garrett-Sinha,et al.  Spi-1 and Spi-B control the expression of the Grap2 gene in B cells. , 2005, Gene.

[24]  D. Allman,et al.  Models for peripheral B cell development and homeostasis. , 2005, Seminars in immunology.

[25]  B. Blom,et al.  The ETS Transcription Factor Spi-B Is Required for Human Plasmacytoid Dendritic Cell Development , 2004, The Journal of experimental medicine.

[26]  L. Staudt,et al.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. , 2004, Blood.

[27]  R. DeKoter,et al.  Analysis of Gene Expression and Ig Transcription in PU.1/Spi-B-Deficient Progenitor B Cell Lines1 , 2004, The Journal of Immunology.

[28]  Colleen M. Witt,et al.  Notch2 Haploinsufficiency Results in Diminished B1 B Cells and a Severe Reduction in Marginal Zone B Cells 1 , 2003, The Journal of Immunology.

[29]  T. Kurosaki,et al.  Coupling Between B Cell Receptor and Phospholipase C-γ2 Is Essential for Mature B Cell Development , 2003, The Journal of experimental medicine.

[30]  T. Leanderson,et al.  SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus. , 2003, Molecular immunology.

[31]  I. Berberich,et al.  Pax‐5 is a key regulator of the B cell‐restricted expression of the CD23a isoform , 2003, European journal of immunology.

[32]  S. Aizawa,et al.  Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. , 2003, Immunity.

[33]  H. Spits,et al.  The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development , 2003 .

[34]  T. Leanderson,et al.  Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C. , 2002, Gene.

[35]  J. Kearney,et al.  CD9 Is a Unique Marker for Marginal Zone B Cells, B1 Cells, and Plasma Cells in Mice1 , 2002, The Journal of Immunology.

[36]  K. Sonoda,et al.  CD1d on antigen‐transporting APC and splenic marginal zone B cells promotes NKT cell‐dependent tolerance , 2002, European journal of immunology.

[37]  T. Wirth,et al.  Reduction of marginal zone B cells in CD22‐deficient mice , 2002, European journal of immunology.

[38]  S. Shinton,et al.  Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation1 , 2001, The Journal of Immunology.

[39]  L. Garrett-Sinha,et al.  The Ets Factors PU.1 and Spi-B Regulate the Transcriptionin Vivo of P2Y10, a Lymphoid Restricted Heptahelical Receptor* , 1999, The Journal of Biological Chemistry.

[40]  H. Sakano,et al.  Prf, a novel Ets family protein that binds to the PU.1 binding motif, is specifically expressed in restricted stages of B cell development. , 1999, International immunology.

[41]  P. Sideras,et al.  B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.

[42]  J. Kearney,et al.  IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. , 1999, Journal of immunology.

[43]  A. Mårtensson,et al.  Spi-C, a Novel Ets Protein That Is Temporally Regulated during B Lymphocyte Development* , 1999, The Journal of Biological Chemistry.

[44]  L. Garrett-Sinha,et al.  PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. , 1999, Immunity.

[45]  D. Tenen,et al.  Defective B cell receptor‐mediated responses in mice lacking the Ets protein, Spi‐B , 1997, The EMBO journal.

[46]  J. Kearney,et al.  Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses , 1997, European journal of immunology.

[47]  M. Simon,et al.  The Ets protein Spi-B is expressed exclusively in B cells and T cells during development , 1996, The Journal of experimental medicine.

[48]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[49]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.

[50]  M. Klemsz,et al.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene , 1990, Cell.

[51]  D. Conrad,et al.  The expression of B cell surface receptors. I. The ontogeny and distribution of the murine B cell IgE Fc receptor. , 1988, Journal of immunology.

[52]  R. Bastos,et al.  Molecular structure of the gene and the 5'-flanking region of the human lymphocyte immunoglobulin E receptor. , 1987, Nucleic acids research.

[53]  R. Hardy,et al.  Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence , 1983, Nature.